Stay updated on Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial
Sign up to get notified when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.

Latest updates to the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of a research study on acute kidney injury related to dapagliflozin and the addition of a new registry identifier and version revision.SummaryDifference32%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acute Kidney Injury in Dapagliflozin vs Other Antidiabetics Clinical Trial page.